Selected research
Industry Research
Prenatal Screening Industry Research Report 2026
Market perspective
The global Prenatal Screening market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Prenatal Screening market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Prenatal Screening market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Prenatal Screening market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Prenatal Screening include Thermo Fisher Scientific, Revvity, Quest Diagnostics, MedGenome, Mayo Clinic Laboratories, GeneDx, PreventionGenetics, SYNLAB and Veritas Genetics, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Prenatal Screening market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Prenatal Screening.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Prenatal Screening Market by Company
Thermo Fisher Scientific
Revvity
Quest Diagnostics
MedGenome
Mayo Clinic Laboratories
GeneDx
PreventionGenetics
SYNLAB
Veritas Genetics
GGA
Cordlife
Rainbow Genomics
BGI Genomics
Berry Genomics
Annaroad
Jiajian Medical Testing
Genesky
Weihansi Biomedical Technology
Prenatal Screening Segment by Type
Serum Biomarker Screening
Ultrasonographic Imaging Screening
Others
Prenatal Screening Segment by Application
Public Hospitals
Private Hospitals
Prenatal Screening Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prenatal Screening market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Prenatal Screening and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prenatal Screening.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Prenatal Screening companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Serum Biomarker Screening
- Ultrasonographic Imaging Screening
- Others
Applications
- Public Hospitals
- Private Hospitals
Companies covered
- Thermo Fisher Scientific
- Revvity
- Quest Diagnostics
- MedGenome
- Mayo Clinic Laboratories
- GeneDx
- PreventionGenetics
- SYNLAB
- Veritas Genetics
- GGA
- Cordlife
- Rainbow Genomics
- BGI Genomics
- Berry Genomics
- Annaroad
- Jiajian Medical Testing
- Genesky
- Weihansi Biomedical Technology
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Prenatal Screening by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Serum Biomarker Screening
- 2.2.3 Ultrasonographic Imaging Screening
- 2.2.4 Others
- 2.3 Prenatal Screening by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Public Hospitals
- 2.3.3 Private Hospitals
- 2.4 Assumptions and Limitations
3 Prenatal Screening Breakdown Data by Type
- 3.1 Global Prenatal Screening Historic Market Size by Type (2021-2026)
- 3.2 Global Prenatal Screening Forecasted Market Size by Type (2027-2032)
4 Prenatal Screening Breakdown Data by Application
- 4.1 Global Prenatal Screening Historic Market Size by Application (2021-2026)
- 4.2 Global Prenatal Screening Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Prenatal Screening Market Perspective (2021-2032)
- 5.2 Global Prenatal Screening Growth Trends by Region
- 5.2.1 Global Prenatal Screening Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Prenatal Screening Historic Market Size by Region (2021-2026)
- 5.2.3 Prenatal Screening Forecasted Market Size by Region (2027-2032)
- 5.3 Prenatal Screening Market Dynamics
- 5.3.1 Prenatal Screening Industry Trends
- 5.3.2 Prenatal Screening Market Drivers
- 5.3.3 Prenatal Screening Market Challenges
- 5.3.4 Prenatal Screening Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Prenatal Screening Players by Revenue
- 6.1.1 Global Top Prenatal Screening Players by Revenue (2021-2026)
- 6.1.2 Global Prenatal Screening Revenue Market Share by Players (2021-2026)
- 6.2 Global Prenatal Screening Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Prenatal Screening Head Office and Area Served
- 6.4 Global Prenatal Screening Players, Product Type & Application
- 6.5 Global Prenatal Screening Manufacturers Established Date
- 6.6 Global Prenatal Screening Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Prenatal Screening Market Size (2021-2032)
- 7.2 North America Prenatal Screening Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Prenatal Screening Market Size by Country (2021-2026)
- 7.4 North America Prenatal Screening Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Prenatal Screening Market Size (2021-2032)
- 8.2 Europe Prenatal Screening Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Prenatal Screening Market Size by Country (2021-2026)
- 8.4 Europe Prenatal Screening Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Prenatal Screening Market Size (2021-2032)
- 9.2 Asia-Pacific Prenatal Screening Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Prenatal Screening Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Prenatal Screening Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Prenatal Screening Market Size (2021-2032)
- 10.2 South America Prenatal Screening Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Prenatal Screening Market Size by Country (2021-2026)
- 10.4 South America Prenatal Screening Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Prenatal Screening Market Size (2021-2032)
- 11.2 Middle East & Africa Prenatal Screening Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Prenatal Screening Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Prenatal Screening Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Thermo Fisher Scientific
- 12.1.1 Thermo Fisher Scientific Company Information
- 12.1.2 Thermo Fisher Scientific Business Overview
- 12.1.3 Thermo Fisher Scientific Revenue in Prenatal Screening Business (2021-2026)
- 12.1.4 Thermo Fisher Scientific Prenatal Screening Product Portfolio
- 12.1.5 Thermo Fisher Scientific Recent Developments
- 12.2 Revvity
- 12.2.1 Revvity Company Information
- 12.2.2 Revvity Business Overview
- 12.2.3 Revvity Revenue in Prenatal Screening Business (2021-2026)
- 12.2.4 Revvity Prenatal Screening Product Portfolio
- 12.2.5 Revvity Recent Developments
- 12.3 Quest Diagnostics
- 12.3.1 Quest Diagnostics Company Information
- 12.3.2 Quest Diagnostics Business Overview
- 12.3.3 Quest Diagnostics Revenue in Prenatal Screening Business (2021-2026)
- 12.3.4 Quest Diagnostics Prenatal Screening Product Portfolio
- 12.3.5 Quest Diagnostics Recent Developments
- 12.4 MedGenome
- 12.4.1 MedGenome Company Information
- 12.4.2 MedGenome Business Overview
- 12.4.3 MedGenome Revenue in Prenatal Screening Business (2021-2026)
- 12.4.4 MedGenome Prenatal Screening Product Portfolio
- 12.4.5 MedGenome Recent Developments
- 12.5 Mayo Clinic Laboratories
- 12.5.1 Mayo Clinic Laboratories Company Information
- 12.5.2 Mayo Clinic Laboratories Business Overview
- 12.5.3 Mayo Clinic Laboratories Revenue in Prenatal Screening Business (2021-2026)
- 12.5.4 Mayo Clinic Laboratories Prenatal Screening Product Portfolio
- 12.5.5 Mayo Clinic Laboratories Recent Developments
- 12.6 GeneDx
- 12.6.1 GeneDx Company Information
- 12.6.2 GeneDx Business Overview
- 12.6.3 GeneDx Revenue in Prenatal Screening Business (2021-2026)
- 12.6.4 GeneDx Prenatal Screening Product Portfolio
- 12.6.5 GeneDx Recent Developments
- 12.7 PreventionGenetics
- 12.7.1 PreventionGenetics Company Information
- 12.7.2 PreventionGenetics Business Overview
- 12.7.3 PreventionGenetics Revenue in Prenatal Screening Business (2021-2026)
- 12.7.4 PreventionGenetics Prenatal Screening Product Portfolio
- 12.7.5 PreventionGenetics Recent Developments
- 12.8 SYNLAB
- 12.8.1 SYNLAB Company Information
- 12.8.2 SYNLAB Business Overview
- 12.8.3 SYNLAB Revenue in Prenatal Screening Business (2021-2026)
- 12.8.4 SYNLAB Prenatal Screening Product Portfolio
- 12.8.5 SYNLAB Recent Developments
- 12.9 Veritas Genetics
- 12.9.1 Veritas Genetics Company Information
- 12.9.2 Veritas Genetics Business Overview
- 12.9.3 Veritas Genetics Revenue in Prenatal Screening Business (2021-2026)
- 12.9.4 Veritas Genetics Prenatal Screening Product Portfolio
- 12.9.5 Veritas Genetics Recent Developments
- 12.10 GGA
- 12.10.1 GGA Company Information
- 12.10.2 GGA Business Overview
- 12.10.3 GGA Revenue in Prenatal Screening Business (2021-2026)
- 12.10.4 GGA Prenatal Screening Product Portfolio
- 12.10.5 GGA Recent Developments
- 12.11 Cordlife
- 12.11.1 Cordlife Company Information
- 12.11.2 Cordlife Business Overview
- 12.11.3 Cordlife Revenue in Prenatal Screening Business (2021-2026)
- 12.11.4 Cordlife Prenatal Screening Product Portfolio
- 12.11.5 Cordlife Recent Developments
- 12.12 Rainbow Genomics
- 12.12.1 Rainbow Genomics Company Information
- 12.12.2 Rainbow Genomics Business Overview
- 12.12.3 Rainbow Genomics Revenue in Prenatal Screening Business (2021-2026)
- 12.12.4 Rainbow Genomics Prenatal Screening Product Portfolio
- 12.12.5 Rainbow Genomics Recent Developments
- 12.13 BGI Genomics
- 12.13.1 BGI Genomics Company Information
- 12.13.2 BGI Genomics Business Overview
- 12.13.3 BGI Genomics Revenue in Prenatal Screening Business (2021-2026)
- 12.13.4 BGI Genomics Prenatal Screening Product Portfolio
- 12.13.5 BGI Genomics Recent Developments
- 12.14 Berry Genomics
- 12.14.1 Berry Genomics Company Information
- 12.14.2 Berry Genomics Business Overview
- 12.14.3 Berry Genomics Revenue in Prenatal Screening Business (2021-2026)
- 12.14.4 Berry Genomics Prenatal Screening Product Portfolio
- 12.14.5 Berry Genomics Recent Developments
- 12.15 Annaroad
- 12.15.1 Annaroad Company Information
- 12.15.2 Annaroad Business Overview
- 12.15.3 Annaroad Revenue in Prenatal Screening Business (2021-2026)
- 12.15.4 Annaroad Prenatal Screening Product Portfolio
- 12.15.5 Annaroad Recent Developments
- 12.16 Jiajian Medical Testing
- 12.16.1 Jiajian Medical Testing Company Information
- 12.16.2 Jiajian Medical Testing Business Overview
- 12.16.3 Jiajian Medical Testing Revenue in Prenatal Screening Business (2021-2026)
- 12.16.4 Jiajian Medical Testing Prenatal Screening Product Portfolio
- 12.16.5 Jiajian Medical Testing Recent Developments
- 12.17 Genesky
- 12.17.1 Genesky Company Information
- 12.17.2 Genesky Business Overview
- 12.17.3 Genesky Revenue in Prenatal Screening Business (2021-2026)
- 12.17.4 Genesky Prenatal Screening Product Portfolio
- 12.17.5 Genesky Recent Developments
- 12.18 Weihansi Biomedical Technology
- 12.18.1 Weihansi Biomedical Technology Company Information
- 12.18.2 Weihansi Biomedical Technology Business Overview
- 12.18.3 Weihansi Biomedical Technology Revenue in Prenatal Screening Business (2021-2026)
- 12.18.4 Weihansi Biomedical Technology Prenatal Screening Product Portfolio
- 12.18.5 Weihansi Biomedical Technology Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst